Clinical trials
Phase 1 Breast Neoplasms trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Unknown status | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Eli Lilly and Company | 2 |
| National University Hospital, Singapore | 2 |
| AstraZeneca | 1 |
| Atavistik Bio, Inc | 1 |
| Iksuda Therapeutics Ltd. | 1 |
| National Cancer Centre, Singapore | 1 |
| Prelude Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 14 |
| Endometrial Neoplasms | 4 |
| Triple Negative Breast Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Colonic Neoplasms | 2 |
| Colorectal Neoplasms | 2 |
| Glioblastoma | 2 |
| Lung Neoplasms | 2 |
| Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.